Feedback / Questions
monalizumab (IPH2201) - AstraZeneca, Innate
Erbitux (cetuximab) - Eli Lilly
http://clinicaltrials.gov/ct2/show/NCT04590963
Dec 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next